The earnings call highlighted Colgate-Palmolive's ability to grow organic sales and make strategic acquisitions, such as Prime100, while also dealing with ongoing challenges in raw material costs, tariffs, and market softness in key regions. The company's commitment to innovation and reductions in tariff exposure partly offset these challenges.

Company Guidance

During the Colgate-Palmolive 2025 Second Quarter Conference Call, the company provided an overview of its guidance, emphasizing its resilience in a challenging environment. Despite pressures from raw material costs and foreign exchange, Colgate-Palmolive achieved a 2.4% organic sales growth, driven by improvements in North America and Africa/Eurasia. The company also highlighted its strategic focus on innovation, with significant product launches and the acquisition of Prime100. Looking ahead, they are prepared to navigate volatility with a productivity initiative aimed at driving growth and efficiency, projecting $200-$300 million in savings over three years. They expect organic sales to improve slightly in the second half of the year, with a focus on price pack architecture and revenue growth management to offset continued cost pressures. The company reaffirmed its commitment to long-term growth, leveraging AI and analytics to optimize performance, while maintaining a low single-digit EPS growth expectation for 2025.

Organic Sales Growth

Organic sales growth accelerated by 60 basis points to 2.4% in the second quarter, driven by improvements in North America and Africa/Eurasia.

Acquisition of Prime100

Colgate-Palmolive closed the acquisition of Prime100, the #1 vet-recommended fresh pet food brand in Australia.

Hill's Pet Nutrition Performance

Hill's delivered mid-single-digit organic growth across almost every hub, including the U.S. and Europe, in a flat category environment.

Commitment to Innovation

Colgate-Palmolive continues to invest in innovation, launching products like Colgate Miracle Repair serum and EltaMD UV skin recovery.

Reduction in Tariff Impact

Tariff exposure was reduced from the previous expectation of $200 million to $75 million.

Colgate-Palmolive (CL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CL Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 31, 2025	2025 (Q3)	0.91 / -	0.91	―	―	―
Aug 01, 2025	2025 (Q2)	0.90 / 0.92	0.91	1.10% (+0.01)
Apr 25, 2025	2025 (Q1)	0.86 / 0.91	0.86	5.81% (+0.05)
Jan 31, 2025	2024 (Q4)	0.89 / 0.91	0.87	4.60% (+0.04)
Oct 25, 2024	2024 (Q3)	0.89 / 0.91	0.86	5.81% (+0.05)
Jul 26, 2024	2024 (Q2)	0.87 / 0.91	0.77	18.18% (+0.14)
Apr 26, 2024	2024 (Q1)	0.81 / 0.86	0.73	17.81% (+0.13)
Jan 26, 2024	2023 (Q4)	0.85 / 0.87	0.77	12.99% (+0.10)
Oct 27, 2023	2023 (Q3)	0.80 / 0.86	0.74	16.22% (+0.12)
Jul 28, 2023	2023 (Q2)	0.75 / 0.77	0.72	6.94% (+0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CL Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 01, 2025	$83.85	$83.51	-0.41%
Apr 25, 2025	$92.15	$93.35	+1.30%
Jan 31, 2025	$89.84	$85.70	-4.61%
Oct 25, 2024	$98.04	$93.98	-4.14%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.